CIK 0001982708 · In Vitro & In Vivo Diagnostic Substances (SIC 2835) · Nasdaq · incorporated in E9 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-07-09 | F-3ASR | AUTOMATIC SHELF REGISTRATION STATEMENT OF SECURITIES OF WELL-KNOWN SEASONED ISSU | |
| 2026-06-12 | 3 | 3 | 2026-03-18 |
| 2026-06-12 | 3 | 3 | 2026-03-18 |
| 2026-05-19 | 6-K | FORM 6-K | 2026-05-19 |
| 2026-04-27 | 6-K | FORM 6-K | 2026-04-27 |
| 2026-04-09 | 20-F/A | FORM 20-F/A1 | 2025-12-31 |
| 2026-04-08 | 3 | 3 | 2026-03-18 |
| 2026-04-08 | 3 | 3 | 2026-03-18 |
| 2026-04-08 | 3 | 3 | 2026-03-18 |
| 2026-04-08 | 3 | 3 | 2026-03-18 |
| 2026-04-08 | 3 | 3 | 2026-03-18 |
| 2026-04-07 | 20-F | FORM 20-F | 2025-12-31 |
| 2026-02-17 | 6-K | FORM 6-K | 2026-02-17 |
| 2026-01-26 | 6-K | FORM 6-K | 2026-01-26 |
| 2025-12-30 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-12-30 |
| 2025-11-13 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-11-12 |
| 2025-04-28 | 20-F | ANNUAL REPORT | 2024-12-31 |
| 2025-02-21 | 6-K | REPORT OF FOREIGN PRIVATE ISSUER | 2025-02-21 |
| 2025-02-19 | 424B4 | PROSPECTUS | |
| 2025-02-18 | EFFECT | EFFECT items ,, | |
| 2025-02-18 | CERT | CERT | |
| 2025-02-14 | CORRESP | CORRESP | |
| 2025-02-14 | CORRESP | CORRESP | |
| 2025-02-14 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | |
| 2025-02-10 | F-1/A | REGISTRATION STATEMENT |
Forms on file (last 1,000): 3 7, 6-K 7, DRS/A 5, DRSLTR 4, UPLOAD 4, F-1/A 3, 20-F 2, CORRESP 2. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=NNNN (0.002 USD), /gw/filings/filings?ticker=NNNN&form=8-K, /gw/filings/facts?ticker=NNNN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange